Autopsy report · NCT04539873

Impact of Colchicine in Hospitalized Colombian Patients With COVID-19

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“non-inclusion of patients in the study effectively”

The sponsor’s own words in the registry.

Life of this trial

Registered 8 months before it started.
Ran for about 6 months before it stopped.
128 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: Fundación Universitaria de Ciencias de la Salud
Sponsor type: University, hospital or other
Conditions: Corona Virus Infection
Interventions: Colchicine 0.5 MG; CONTROL GROUP
Participants: 128
Sites: 1
Countries: Colombia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.